May 2025 PMID 39870328

Efficacy and safety of Hibiscus sabdariffa in cardiometabolic health: An overview of reviews and updated dose-response meta-analysis.

Mostafa Norouzzadeh, Minoo Hasan Rashedi, Mohammad Hesam Azizi, Farshad Teymoori, Zohreh Maghsoomi, Farzad Shidfar

Full text PDF Download social card

Mentions

Peak: 3 in Nov 2025

across 3 sources since Feb 2025

Extended reach

885

potential audience

Total likes

Video views

Mentions per month

Feb 2025 – Nov 2025

Where it's discussed

YouTube3 videos
News2 articles
X / Twitter1 posts

AI synopsis

What people are saying

Examples include comments like 'Hibiscus shows promise for blood pressure management,' indicating recognition of the study's findings, and posts asking about how to incorporate it into daily routines, which reflect moderate interest. The tone is respectful and somewhat optimistic but lacks critical debate, highlighting general awareness rather than profound impact.

AgreementModerate agreement

Most discussions acknowledge the potential benefits of Hibiscus sabdariffa highlighted in the publication, though some express cautious optimism.

InterestModerate interest

Participants show moderate curiosity about the research, with some comments requesting more detailed information or discussing practical applications.

EngagementNeutral engagement

The comments tend to be surface-level, mainly sharing opinions or brief summaries without deep analysis.

ImpactModerate impact

The overall influence appears moderate, with some users noting the relevance of natural remedies but not demonstrating widespread behavioral change.

Abstract in brief

This study reviewed multiple meta-analyses to assess the effectiveness and safety of Hibiscus sabdariffa (HS) as an alternative treatment for cardiometabolic issues, finding that HS can effectively reduce blood pressure and improve cholesterol and blood sugar levels, especially in older adults and over longer treatment durations.
The evidence suggests that HS’s blood pressure-lowering effects are comparable to conventional antihypertensive drugs, with moderate certainty, but safety considerations for long-term use still need careful monitoring due to minor liver enzyme changes.
Overall, HS appears to be a promising, natural supplement for managing cardiometabolic health with a good safety profile, though further high-quality research is needed to confirm its long-term safety and effectiveness.

Read the full abstract